Compass Capital Management Inc. increased its holdings in CVS Health Corp (NYSE:CVS) by 2.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 301,429 shares of the pharmacy operator’s stock after purchasing an additional 6,715 shares during the period. CVS Health accounts for 3.9% of Compass Capital Management Inc.’s investment portfolio, making the stock its 13th biggest position. Compass Capital Management Inc.’s holdings in CVS Health were worth $24,512,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in CVS. FMR LLC grew its position in CVS Health by 22.0% during the second quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock valued at $2,425,920,000 after acquiring an additional 5,446,930 shares during the period. Boston Partners grew its position in CVS Health by 69.1% during the second quarter. Boston Partners now owns 6,459,237 shares of the pharmacy operator’s stock valued at $519,711,000 after acquiring an additional 2,638,888 shares during the period. Parametric Portfolio Associates LLC grew its position in CVS Health by 71.5% during the second quarter. Parametric Portfolio Associates LLC now owns 3,949,854 shares of the pharmacy operator’s stock valued at $317,805,000 after acquiring an additional 1,647,168 shares during the period. Prudential Financial Inc. grew its position in CVS Health by 61.8% during the second quarter. Prudential Financial Inc. now owns 2,946,531 shares of the pharmacy operator’s stock valued at $237,078,000 after acquiring an additional 1,125,400 shares during the period. Finally, Nordea Investment Management AB grew its position in CVS Health by 8.4% during the second quarter. Nordea Investment Management AB now owns 14,154,922 shares of the pharmacy operator’s stock valued at $1,138,905,000 after acquiring an additional 1,100,373 shares during the period. 81.64% of the stock is owned by institutional investors and hedge funds.

A number of research firms have issued reports on CVS. Robert W. Baird restated a “hold” rating and set a $77.00 price objective on shares of CVS Health in a research note on Friday, October 27th. Needham & Company LLC upgraded CVS Health from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $69.02 to $79.00 in a research note on Friday, November 10th. Deutsche Bank restated a “hold” rating on shares of CVS Health in a research note on Tuesday, December 5th. Mizuho set a $90.00 price objective on CVS Health and gave the stock a “buy” rating in a research note on Tuesday, October 24th. Finally, Raymond James Financial reiterated a “buy” rating on shares of CVS Health in a research note on Monday, December 4th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $87.49.

In other CVS Health news, EVP Lisa Bisaccia sold 29,445 shares of the company’s stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $75.00, for a total value of $2,208,375.00. Following the completion of the sale, the executive vice president now directly owns 15,556 shares in the company, valued at $1,166,700. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.61% of the company’s stock.

CVS Health Corp (NYSE:CVS) opened at $83.63 on Tuesday. CVS Health Corp has a fifty-two week low of $66.45 and a fifty-two week high of $84.00. The stock has a market capitalization of $83,075.48, a P/E ratio of 14.36, a P/E/G ratio of 1.29 and a beta of 0.90. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.05 and a quick ratio of 0.55.

CVS Health (NYSE:CVS) last released its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.01. The firm had revenue of $46.18 billion during the quarter, compared to the consensus estimate of $46.17 billion. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The firm’s revenue for the quarter was up 3.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.64 earnings per share. analysts anticipate that CVS Health Corp will post 5.88 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, February 2nd. Shareholders of record on Wednesday, January 24th will be given a $0.50 dividend. The ex-dividend date is Tuesday, January 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.39%. CVS Health’s dividend payout ratio (DPR) is 41.32%.

TRADEMARK VIOLATION WARNING: “CVS Health Corp (CVS) Shares Bought by Compass Capital Management Inc.” was originally reported by Marea Informative and is the sole property of of Marea Informative. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.mareainformativa.com/cvs-health-corp-cvs-position-boosted-by-compass-capital-management-inc-updated-updated-updated/126129/.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.